Rupert McShane MD (Oxon) FRCPsych
Rupert McShane is clinical lead for the Thames Valley Dementias and Neurodegenerative Diseases local research network. As well as being a PI on several dementia trials, he has led studies of diagnostic tests based on olfactory function, willingness to pay for care, assistive technology, and ketamine as a treatment for depression. He is the Coordinating Editor of the Cochrane Dementia and Cognitive Improvement Group.
Research Areas
Recent Publications
- Hermans DG, Htay UH, and McShane Rupert (2007) Non-pharmacological interventions for wandering of people with dementia in the domestic setting Cochrane Database Syst Rev, 24(1):CD005994.
- Jenagaratnam Lydia and McShane Rupert (2006) Clioquinol for the treatment of Alzheimer's Disease Cochrane Database Systematic Reviews, 25(1):CD005380.
- McShane Rupert, Areosa Sastre A, and Minakaran N (2006) Memantine for dementia Cochrane Database Systematic Reviews, 19(2):CD003154.
- van der Putt Rohan, Dineen Catherine, Janes David, Series Hugh, and McShane Rupert (2006) Effectiveness of acetylcholinesterase inhibitors: diagnosis and severity as predictors of response in routine practice International Journal of Geriatric Psychiatry, 21(8):755-760.